Ark Invest Boosts Nvidia and Intellia Stakes Reduces AMD
Cathie Wood’s Ark Invest made significant moves in its latest portfolio adjustments, focusing heavily on semiconductor, biotechnology, and technology sectors. The firm increased its holdings in Nvidia (NVDA) and Intellia Therapeutics (NTLA) during the week ended October 2, 2026. Ark Invest acquired 356,681 shares of Nvidia, underscoring its confidence in the company’s growth prospects.
Intellia Therapeutics also saw substantial buying activity, reflecting Ark Invest’s bullish stance on the biotechnology sector. Meanwhile, the firm reduced its position in Advanced Micro Devices (AMD), indicating a strategic shift in its investment approach.
The adjustments were part of broader changes across Ark Invest’s various exchange-traded funds (ETFs), including ARK Innovation ETF (ARKK), ARKG, ARKF, ARKQ, ARKW, and ARKX. Other notable holdings mentioned include Amazon (AMZN), Tesla (TSLA), Palantir (PLTR), and Rocket Lab (RKLB).